Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (231-240 of 740) with videos related to

Pageof 74
Sort By:
Leukemia & Lymphoma|February 12, 2024
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparisonKatja Weisel, Meletios A Dimopoulos, Meral Beksac, et al.
Urologic Oncology|December 15, 2015
Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancerAlexandros Drivalos, Michael Chrisofos, Eleni Efstathiou, et al.
Anticancer Research|August 17, 2005
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literatureDimitrios Pectasides, Gerasimos Aravantinos, George Fountzilas, et al.
Leukemia Research|June 1, 2010
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agentsMaria Roussou, Efstathios Kastritis, Dimitrios Christoulas, et al.
Leukemia & Lymphoma|October 7, 2014
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agentsMorie A Gertz, Evangelos Terpos, Angela Dispenzieri, et al.
Urology|April 11, 2008
Biweekly doxorubicin/ketoconazole as second-line treatment in docetaxel-resistant, hormone-refractory prostate cancerGeorge Lainakis, Antoniou Nikos, Alivizatos Gerassimos, et al.
American Journal of Hematology|April 14, 2020
Hematological findings and complications of COVID-19Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Ismail Elalamy, et al.
Clinical Lymphoma|January 11, 2003
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemiaMeletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, et al.
Cancer Treatment Reviews|August 24, 2019
Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysisFlora Zagouri, Anna-Maria Korakiti, Roubini Zakopoulou, et al.
Oncology|May 15, 2008
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessmentAristotle Bamias, George Lainakis, Efstathios Kastritis, et al.
Pageof 74

Showing results (231-240 of 740) with videos related to

Sort By:
Pageof 74
Leukemia & Lymphoma|February 12, 2024
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparisonKatja Weisel, Meletios A Dimopoulos, Meral Beksac, et al.
Urologic Oncology|December 15, 2015
Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancerAlexandros Drivalos, Michael Chrisofos, Eleni Efstathiou, et al.
Anticancer Research|August 17, 2005
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literatureDimitrios Pectasides, Gerasimos Aravantinos, George Fountzilas, et al.
Leukemia Research|June 1, 2010
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agentsMaria Roussou, Efstathios Kastritis, Dimitrios Christoulas, et al.
Leukemia & Lymphoma|October 7, 2014
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agentsMorie A Gertz, Evangelos Terpos, Angela Dispenzieri, et al.
Urology|April 11, 2008
Biweekly doxorubicin/ketoconazole as second-line treatment in docetaxel-resistant, hormone-refractory prostate cancerGeorge Lainakis, Antoniou Nikos, Alivizatos Gerassimos, et al.
American Journal of Hematology|April 14, 2020
Hematological findings and complications of COVID-19Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Ismail Elalamy, et al.
Clinical Lymphoma|January 11, 2003
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemiaMeletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, et al.
Cancer Treatment Reviews|August 24, 2019
Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysisFlora Zagouri, Anna-Maria Korakiti, Roubini Zakopoulou, et al.
Oncology|May 15, 2008
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessmentAristotle Bamias, George Lainakis, Efstathios Kastritis, et al.
Pageof 74